NH NongwoobioNH농우바이오
054050 · KOSDAQ · ₩054050 · NH농우바이오
₩6,680▼ ₩80 (1.18%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩159B | ₩145B | ₩136B | ₩146B | ₩133B |
| Cost of sales | ₩81B | ₩73B | ₩70B | ₩77B | ₩70B |
| Gross profit | ₩78B | ₩72B | ₩66B | ₩69B | ₩63B |
| Operating income | ₩14B | ₩11B | ₩8.9B | ₩11B | ₩6.8B |
| Net income | ₩12B | ₩11B | ₩10B | ₩9.8B | ₩7B |
| Net income to shareholders | ₩12B | ₩11B | ₩10B | ₩9.8B | ₩7B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩353B | ₩343B | ₩324B | ₩327B | ₩311B |
| Current assets | ₩226B | ₩214B | ₩202B | ₩201B | ₩179B |
| Cash and equivalents | ₩48B | ₩40B | ₩34B | ₩24B | ₩15B |
| Total liabilities | ₩75B | ₩72B | ₩66B | ₩77B | ₩67B |
| Current liabilities | ₩68B | ₩56B | ₩62B | ₩73B | ₩61B |
| Borrowings | ₩22B | ₩20B | ₩21B | ₩29B | ₩21B |
| Total equity | ₩278B | ₩272B | ₩8B | ₩53B | ₩244B |
| Shareholders' equity | ₩278B | ₩271B | ₩257B | ₩249B | ₩244B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩15B | ₩19B | ₩16B | ₩9.7B | ₩3.9B |
| Free cash flow | ₩15B | ₩19B | ₩16B | ₩9.7B | ₩3.9B |
| Dividends paid | ₩3.5B | — | — | — | — |
Consolidated where available. Amounts in won.
Also known as: NH Nongwoobio / NH농우바이오 / 054050 / KRX:054050
Source: KRX statistical information